Should Lucas Film Change Course After Mandalorian And Grogu Box Office Disappointment?!

The movie news cycle is heating up, and today on The Kristian Harloff Show we're breaking down some of the biggest stories shaking up Hollywood! First, the surprise box office and streaming success of *Backrooms* and *Obsession* has the entertainment industry taking notice. What does this mean for the future of original genre films and independent filmmaking? Plus, Emily Blunt reportedly turned down the use of AI technology for her upcoming project *Disclosure Day*. As artificial intelligence continues to spark debate throughout Hollywood, what impact could this decision have on the industry moving forward? Then, Nicolas Cage opens up about the future of *Spider-Noir*, including the chances of a Season 2. We also discuss the shocking revelation that the first season reportedly required a year of reshoots and carries a massive production budget. Marvel fans won't want to miss our discussion on *Avengers: Doomsday*. Did the Russo Brothers just tease the release date for the first trailer? We break down the latest speculation and what it could mean for the future of the MCU. Finally, DC fans have reason to be excited as *Man of Tomorrow* prepares for external filming. What does this mean for the highly anticipated project and the future of DC Studios? Join Kristian Harloff as he delivers the latest movie news, Marvel updates, DC news, box office analysis, industry insights, and everything happening in the world of film and television. SPONSORS: LIQUID IV: Go to https://www.LIQUIDIV.com and get 20% off your first purchase with code KRISTIAN at checkout RUGIET: Head to https://www.rugiet.com/KRISTIAN and get 15% off your ED treatment. HIMS: Ready to reach your goals? Visit https://www.hims.com/KRISTIAN to get a personalized, affordable plan that gets you. - Based on advertised cash price for 30-day supply of medication only. Membership required, fee not included, and billed separately. Weight Loss by Hims is not available in all 50 states. Wegovy® is the registered trademark of Novo Nordisk A.S. To get started and learn more, including important safety information, Wegovy® clinical study information, and restrictions, visit https://www.hims.com